Greenwood Capital Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,197
| Closed | -$550K | – | 176 |
|
|
2019
Q1 | $550K | Buy |
6,197
+745
| +14% | +$66.1K | 0.14% | 88 |
|
|
2018
Q4 | $464K | Buy |
5,452
+798
| +17% | +$67.9K | 0.12% | 100 |
|
|
2018
Q3 | $451K | Sell |
4,654
-15
| -0.3% | -$1.45K | 0.1% | 114 |
|
|
2018
Q2 | $440K | Buy |
4,669
+415
| +10% | +$39.1K | 0.1% | 108 |
|
|
2018
Q1 | $345K | Buy |
4,254
+395
| +10% | +$32K | 0.08% | 129 |
|
|
2017
Q4 | $344K | Sell |
3,859
-1,875
| -33% | -$167K | 0.08% | 143 |
|
|
2017
Q3 | $534K | Sell |
5,734
-165
| -3% | -$15.4K | 0.13% | 104 |
|
|
2017
Q2 | $536K | Buy |
5,899
+337
| +6% | +$30.6K | 0.14% | 102 |
|
|
2017
Q1 | $488K | Buy |
5,562
+1,272
| +30% | +$112K | 0.13% | 110 |
|
|
2016
Q4 | $355K | Sell |
4,290
-240
| -5% | -$19.9K | 0.1% | 121 |
|
|
2016
Q3 | $419K | Buy |
+4,530
| New | +$419K | 0.13% | 106 |
|
|
2015
Q3 | – | Sell |
-1,530
| Closed | -$209K | – | 157 |
|
|
2015
Q2 | $209K | Buy |
+1,530
| New | +$209K | 0.06% | 149 |
|